Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 668 participants.

Also called NCT04886388

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 668 participants (enrolled count) (from the registry)
Sponsor
Better Therapeutics (from the registry)
Registry
  • NCT NCT04886388
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04886388. Randomized; no masking; primary purpose treatment. Start 2021-04-22 (actual); primary completion 2022-03-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes
Intervention (Device)
BT-001
Intervention (Other)
Physician-guided Standard of Care for type 2 diabetes
Lead sponsor
Better Therapeutics (class: industry)

Record details

Record id
cardio:ct-nct04886388
Content hash
69899c39c4d3428a31260749dd42b1a54c64bec580577da88a674a5a9cf1cd2c